BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25981045)

  • 1. Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity.
    Kane JR; Stanley DJ; Hultquist JF; Johnson JR; Mietrach N; Binning JM; Jónsson SR; Barelier S; Newton BW; Johnson TL; Franks-Skiba KE; Li M; Brown WL; Gunnarsson HI; Adalbjornsdóttir A; Fraser JS; Harris RS; Andrésdóttir V; Gross JD; Krogan NJ
    Cell Rep; 2015 May; 11(8):1236-50. PubMed ID: 25981045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.
    Zhang W; Wang H; Li Z; Liu X; Liu G; Harris RS; Yu XF
    J Virol; 2014 Nov; 88(21):12528-40. PubMed ID: 25142583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for recruitment of host CypA and E3 ubiquitin ligase by maedi-visna virus Vif.
    Hu Y; Gudnadóttir RB; Knecht KM; Arizaga F; Jónsson SR; Xiong Y
    Sci Adv; 2023 Jan; 9(2):eadd3422. PubMed ID: 36638173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.
    Ai Y; Zhu D; Wang C; Su C; Ma J; Ma J; Wang X
    J Virol; 2014 Oct; 88(20):12112-22. PubMed ID: 25122780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.
    Zhang J; Wu J; Wang W; Wu H; Yu B; Wang J; Lv M; Wang X; Zhang H; Kong W; Yu X
    Retrovirology; 2014 Sep; 11():77. PubMed ID: 25213124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
    Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
    J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation.
    Knecht KM; Hu Y; Rubene D; Cook M; Ziegler SJ; Jónsson SR; Xiong Y
    J Biol Chem; 2021; 296():100045. PubMed ID: 33465707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionarily and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins.
    Yoshikawa R; Izumi T; Nakano Y; Yamada E; Moriwaki M; Misawa N; Ren F; Kobayashi T; Koyanagi Y; Sato K
    Microbiol Immunol; 2016 Jun; 60(6):427-36. PubMed ID: 27193350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.
    Liu B; Sarkis PT; Luo K; Yu Y; Yu XF
    J Virol; 2005 Aug; 79(15):9579-87. PubMed ID: 16014920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.
    DeHart JL; Bosque A; Harris RS; Planelles V
    J Virol; 2008 Sep; 82(18):9265-72. PubMed ID: 18596088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
    Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
    Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
    Zhang W; Huang M; Wang T; Tan L; Tian C; Yu X; Kong W; Yu XF
    Cell Microbiol; 2008 Aug; 10(8):1662-75. PubMed ID: 18419775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assembly of Vif ubiquitin E3 ligase for APOBEC3 degradation.
    Kim DY
    Arch Pharm Res; 2015 Apr; 38(4):435-45. PubMed ID: 25408426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Cullin5-ElonginB-ElonginC E3 complex in degradation of feline immunodeficiency virus Vif-mediated feline APOBEC3 proteins.
    Wang J; Zhang W; Lv M; Zuo T; Kong W; Yu X
    J Virol; 2011 Dec; 85(23):12482-91. PubMed ID: 21957297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z; Zhang W; Chen G; Xu R; Yu XF
    J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
    Kim DY; Kwon E; Hartley PD; Crosby DC; Mann S; Krogan NJ; Gross JD
    Mol Cell; 2013 Feb; 49(4):632-44. PubMed ID: 23333304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3.
    Yoshikawa R; Takeuchi JS; Yamada E; Nakano Y; Misawa N; Kimura Y; Ren F; Miyazawa T; Koyanagi Y; Sato K
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.
    Nakano Y; Aso H; Soper A; Yamada E; Moriwaki M; Juarez-Fernandez G; Koyanagi Y; Sato K
    Retrovirology; 2017 May; 14(1):31. PubMed ID: 28482907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.
    Zheng W; Ling L; Li Z; Wang H; Rui Y; Gao W; Wang S; Su X; Wei W; Yu XF
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28122978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.
    Larue RS; Lengyel J; Jónsson SR; Andrésdóttir V; Harris RS
    J Virol; 2010 Aug; 84(16):8193-201. PubMed ID: 20519393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.